Our Board of Directors - Bristol Myers Squibb

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Giovanni Caforio, MD >

Chairman of the Board and Chief Executive Officer

Theodore R. Samuels >

Lead Independent Director and Retired President of Capital Guardian Trust Company

Peter J. Arduini >

President and Chief Executive Officer of GE Healthcare

Deepak L. Bhatt, MD, MPH >

Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine

Chris Boerner, PhD >

Board Member and Executive Vice President, Chief Operating Officer

Julia A. Haller, MD >

Ophthalmologist-in-Chief, Wills Eye Hospital

Manuel Hidalgo Medina, MD, PhD >

Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College and Attending Physician, New York-Presbyterian Hospital

Paula A. Price >

Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.

Derica W. Rice >

Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark. Former Executive Vice President and Chief Financial Officer, Eli Lilly Company

Gerald L. Storch >

Chief Executive Officer, Storch Advisors. Former Chief Executive Officer, Hudson’s Bay Company

Karen H. Vousden, PhD >

Principal Group Leader of The Francis Crick Institute and Former Chief Scientist of Cancer Research UK

Phyllis R. Yale >

Advisory Partner, Bain & Company